Genomictree Inc.
228760
Rang în acțiuni
#19155
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Preț acțiune
$6.62
Capitalizare de piață
$162.43M
Schimbare (1 zi)
0.10%
Schimbare (1 an)
-50.88%
Țară
KR
Tranzacționează Genomictree Inc. (228760)
Categorie
Healthcare
Istoricul randamentului dividendelor pentru Genomictree Inc. (228760)
Randamentul dividendelor (TTM) pentru Genomictree Inc. (simbol acțiune: 228760) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Genomictree Inc. (228760) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
| An | Randamentul dividendelor | Schimbă |
|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | ||
Randamentele dividendelor (TTM) pentru companii similare sau concurente
| Companie | Randamentul dividendelor | Țara |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
